Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Eli Lilly Jumps, Reversing Its Weight-Loss Setback, On A Strong 2025 Outlook
Eli Lilly Jumps, Reversing Its Weight-Loss Setback, On A Strong 2025 Outlook · Investor's Business Daily

In This Article:

Eli Lilly stock rose Thursday despite lighter-than-expected sales of its weight-loss and diabetes drugs Zepbound and Mounjaro.